Aranda Investments Pte. Ltd. - Net Worth and Insider Trading

Aranda Investments Pte. Ltd. Net Worth

The estimated net worth of Aranda Investments Pte. Ltd. is at least $48 Million dollars as of 2024-09-27. Aranda Investments Pte. Ltd. is the of Genor Biopharma Holdings Ltd and owns about 29,157,348 shares of Genor Biopharma Holdings Ltd (HKSE:06998) stock worth over $48 Million. Details can be seen in Aranda Investments Pte. Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aranda Investments Pte. Ltd. has not made any transactions after 2020-11-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Aranda Investments Pte. Ltd.

Aranda Investments Pte. Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aranda Investments Pte. Ltd. owns 1 companies in total, including Genor Biopharma Holdings Ltd (HKSE:06998) .

Click here to see the complete history of Aranda Investments Pte. Ltd.’s form 4 insider trades.

Insider Ownership Summary of Aranda Investments Pte. Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:06998	Genor Biopharma Holdings Ltd	2020-11-02

Aranda Investments Pte. Ltd. Latest Holdings Summary

Aranda Investments Pte. Ltd. currently owns a total of 1 stock. Aranda Investments Pte. Ltd. owns 29,157,348 shares of Genor Biopharma Holdings Ltd (HKSE:06998) as of November 2, 2020, with a value of $48 Million.

Latest Holdings of Aranda Investments Pte. Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06998	Genor Biopharma Holdings Ltd	2020-11-02	29,157,348	1.65	48,109,624

Holding Weightings of Aranda Investments Pte. Ltd.

Aranda Investments Pte. Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Aranda Investments Pte. Ltd. has made a total of 1 transactions in Genor Biopharma Holdings Ltd (HKSE:06998) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Genor Biopharma Holdings Ltd is the sale of 0 shares on November 2, 2020, which brought Aranda Investments Pte. Ltd. around $0.

Insider Trading History of Aranda Investments Pte. Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aranda Investments Pte. Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Aranda Investments Pte. Ltd. Ownership Network

Ownership Network List of Aranda Investments Pte. Ltd.

No Data

Ownership Network Relation of Aranda Investments Pte. Ltd.

Aranda Investments Pte. Ltd. Owned Company Details

What does Genor Biopharma Holdings Ltd do?

Who are the key executives at Genor Biopharma Holdings Ltd?

Aranda Investments Pte. Ltd. is the of Genor Biopharma Holdings Ltd. Other key executives at Genor Biopharma Holdings Ltd include 2102 Investment manager Hillhouse Investment Management, Ltd. , 2101 Beneficial owner Hhjh Holdings Limited , and 2201 Interest of corporation controlled by you Hillhouse Fund IV, L.P. .

Genor Biopharma Holdings Ltd (HKSE:06998) Insider Trades Summary

Over the past 18 months, Aranda Investments Pte. Ltd. made no insider transaction in Genor Biopharma Holdings Ltd (HKSE:06998). Other recent insider transactions involving Genor Biopharma Holdings Ltd (HKSE:06998) include a net sale of 0 shares made by Hillhouse Investment Management, Ltd. ,

In summary, during the past 3 months, insiders sold 0 shares of Genor Biopharma Holdings Ltd (HKSE:06998) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genor Biopharma Holdings Ltd (HKSE:06998) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genor Biopharma Holdings Ltd (HKSE:06998)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genor Biopharma Holdings Ltd Insider Transactions

No Available Data

Aranda Investments Pte. Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Aranda Investments Pte. Ltd.. Currently GuruFocus does not have mailing address information for Aranda Investments Pte. Ltd..

Discussions on Aranda Investments Pte. Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.